Literature DB >> 32043773

In Reply.

Blake Warner1, Alan Baer1,2.   

Abstract

Mesh：

Year:  2019        PMID： 32043773      PMCID： PMC7011669          DOI： 10.1634/theoncologist.2019-0515

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  7 in total

1.  Immune Checkpoint Inhibitor Outcomes for Patients With Non-Small-Cell Lung Cancer Receiving Baseline Corticosteroids for Palliative Versus Nonpalliative Indications.

Authors:  Biagio Ricciuti; Suzanne E Dahlberg; Anika Adeni; Lynette M Sholl; Mizuki Nishino; Mark M Awad
Journal:  J Clin Oncol       Date:  2019-06-17       Impact factor: 44.544

2.  Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary.

Authors:  Julie R Brahmer; Christina Lacchetti; John A Thompson
Journal:  J Oncol Pract       Date:  2018-03-08       Impact factor: 3.840

3.  Sicca Syndrome Induced by Immune Checkpoint Inhibitor Therapy: Optimal Management Still Pending.

Authors:  Ariadna Ortiz Brugués; Vincent Sibaud; Beatrice Herbault-Barrés; Sarah Betrian; Iphigenie Korakis; Caroline De Bataille; Carlos Gomez-Roca; Joel Epstein; Emmanuelle Vigarios
Journal:  Oncologist       Date:  2019-11-06

4.  Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer.

Authors:  Kathryn C Arbour; Laura Mezquita; Niamh Long; Hira Rizvi; Edouard Auclin; Andy Ni; Gala Martínez-Bernal; Roberto Ferrara; W Victoria Lai; Lizza E L Hendriks; Joshua K Sabari; Caroline Caramella; Andrew J Plodkowski; Darragh Halpenny; Jamie E Chaft; David Planchard; Gregory J Riely; Benjamin Besse; Matthew D Hellmann
Journal:  J Clin Oncol       Date:  2018-08-20       Impact factor: 44.544

5.  Profiling Autoantibodies against Salivary Proteins in Sicca Conditions.

Authors:  P D Burbelo; E M N Ferré; A Chaturvedi; J A Chiorini; I Alevizos; M S Lionakis; B M Warner
Journal:  J Dent Res       Date:  2019-05-16       Impact factor: 6.116

6.  Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy.

Authors:  Blake M Warner; Alan N Baer; Evan J Lipson; Clint Allen; Christian Hinrichs; Arun Rajan; Eileen Pelayo; Margaret Beach; James L Gulley; Ravi A Madan; Josephine Feliciano; Margaret Grisius; Lauren Long; Astin Powers; David E Kleiner; Laura Cappelli; Ilias Alevizos
Journal:  Oncologist       Date:  2019-04-17

7.  Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors.

Authors:  Giovanni Fucà; Giulia Galli; Marta Poggi; Giuseppe Lo Russo; Claudia Proto; Martina Imbimbo; Roberto Ferrara; Nicoletta Zilembo; Monica Ganzinelli; Antonio Sica; Valter Torri; Mario Paolo Colombo; Claudio Vernieri; Andrea Balsari; Filippo de Braud; Marina Chiara Garassino; Diego Signorelli
Journal:  ESMO Open       Date:  2019-02-27
  7 in total
  1 in total

Review 1.  Salivary gland function, development, and regeneration.

Authors:  Alejandro M Chibly; Marit H Aure; Vaishali N Patel; Matthew P Hoffman
Journal:  Physiol Rev       Date:  2022-03-28       Impact factor: 46.500
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.